Transcripts MyMD Pharmaceuticals, Inc. Boerse Muenchen

Stocks

Real-time Boerse Muenchen			5-day change	1st Jan Change
- ^EUR	-.--%		+2,616.54%	+1,482.57%

09-30	Q/C Technologies, Inc. and Sandia National Laboratories Announce Research Collaboration	CI
09-14	Q/C Technologies, Inc. Appoints Yossef Ehrlichman as Chief Technology Officer	CI

20-11-18	Akers Biosciences, Inc., MyMD Pharmaceuticals, Inc - M&A Call
20-08-27	Akers Biosciences, Inc. - Shareholder/Analyst Call
17-02-01	Akers Biosciences, Inc. Provides Revenue Guidance for the Year Ended December 31, 2016 and for the Year 2017	CI
12-06-28	Akers Biosciences Inc. Reports Preliminary Consolidated Earnings Results for the Year Ended December 31, 2011; Provides Earnings Guidance for the Third Quarter 2012	CI